Join Us March 13th @ 1 pm ET BEFORE Nvidia’s “Q-Day”

In 2016 Louis Navellier made a big prediction regarding Nvidia’s GPUs... It went up more than 7,000% at its peak. Don’t miss Louis NEXT Nvidia call. (Plus 6 stocks you need to own before March 20th.)

Thu, March 13 at 10:00AM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Why Is Assure (IONM) Stock Down 53% Today?

By William White, InvestorPlace Writer
Assure stock is down on Thursday as IONM investors react to the company terminating a merger agreement with Danam Health.

Why Is Longeveron (LGVN) Stock Up 46% Today?

By William White, InvestorPlace Writer
Longeveron stock is up on Thursday with heavy trading of LGVN shares as the company's units continue to rally on clinical trial news.

Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June

By Rich Duprey, InvestorPlace Contributor
Here are three dividend stocks to buy for your retirement portfolio that should offer rising income beyond the rate of inflation.

3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years

By Ian Cooper, InvestorPlace Contributor
One of the best ways to spot winning stocks to buy is by spotting hot trends, such as artificial intelligence and obesity.

3 Stocks to Buy as Ozempic Surges in Popularity

By Joey Frenette, InvestorPlace Contributor
Ozempic has surged in popularity in recent years, but the best may be to come as innovators look to launch new drugs to meet hot demand.

How to Invest in Penny Stocks in 2024: 3 Best Picks

By Matthew Rodrigues, InvestorPlace Contributor
For investors wondering how to invest in penny stocks, look no further! These three penny stocks all have serious growth potential.

Why Is Longeveron (LGVN) Stock Up 120% Today?

By Chris MacDonald, InvestorPlace Contributor
Let's dive into why shares of Longeveron are surging today, with LGVN stock nearly doubling today on some possible updates.

Blue-Chip Bonanzas: 3 Industry Leaders Trading at Unbelievable Discounts

By Josh Enomoto, InvestorPlace Contributor
When it comes to targeting discounted ideas in the equities sector, undervalued blue-chip stocks offer some of the most compelling prospects. First and foremost, blue…

4 Best Stocks to Buy and 3 Best Stocks to Sell: June 2024

By Joel Baglole, InvestorPlace Contributor
Consider making moves in these securities, each of which has news that is impacting their share price either positively or negatively.

7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom

By Josh Enomoto, InvestorPlace Contributor
Because it’s tied to one of the six leading causes of “finality,” stress represents a silent public health crisis. And few things cause heightened stress…

3 Stocks Quietly Preparing for a 10X Surge: June Edition

By Ian Cooper, InvestorPlace Contributor
There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia.

Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?

By William White, InvestorPlace Writer
Tonix Pharmaceuticals stock is down on Wednesday after the company announced a proposed public offering for TNXP shares.

3 No-Nonsense S&P 500 Stocks to Buy and Hold Forever

By Rich Duprey, InvestorPlace Contributor
Bull markets wipe away all traces of a market crash so buying these S&P 500 stocks for the long haul will ensure outsized returns.

7 Growth Stocks BlackRock Is Buying (and You Should Too)

By Omor Ibne Ehsan
Unlock the potential of these seven growth stocks handpicked by investment giant BlackRock to grow your portfolio.

7 Recession-Proof Stocks to Buy Now for Peace of Mind

By Yiannis Zourmpanos, InvestorPlace Contributor
Dive into the fundamentals behind the resilience of recession-proof stocks and the performance indicators driving their success.

Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug

By William White, InvestorPlace Writer
Eli Lilly stock is up on Tuesday as investors in LLY celebrate an FDA panel putting its support behind the company's Alzheimer's drug.

Dividend Delicacies: 3 Stocks That Will Tantalize Your Taste for Profits

By Nikolaos Sismanis, InvestorPlace Contributor
Explore three dividend stocks with elevated yields, including Enterprise Products Partners, Universal Health Realty, and Enbridge.

3 Promising Penny Stocks With Millionaire-Maker Potential by 2028

By Faisal Humayun, InvestorPlace Contributor
These are the undervalued millionaire-maker penny stocks to buy as they represent fundamentally strong ideas with a robust growth outlook

3 Cannabis Stocks to Buy for 200% Returns Before Year-End

By Faisal Humayun, InvestorPlace Contributor
These are the undervalued cannabis stocks to buy that represent fundamentally good stories with likelihood of revenue acceleration.
Load More Articles